Medical OncologyNCT02327806
The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance
A study testing pulsed electromagnetic field therapy in people with Medical Oncology, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.
Trial summary
Pulsed electromagnetic field therapy (PEMFT) is a reparative technique most commonly used in the field of orthopedics for the treatment of non-union fractures. The aim is to test the effect of the magnetic induction on brute force of treated muscle in oncological patients. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Medical Oncology
- What is being tested?
- pulsed electromagnetic field therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteIsrael
- Study dates
- Jan 2015to Mar 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patiant from the oncology clinic
Who cannot join
- Known bone disease
- Pregnancy
- Birth defects or acquired uper extremity
- Neurology disease
- Medical history in the forehand
- Pacemaker neural modulation pacer.
Trial locations and contacts
1 site in 1 country.
About this study
Pulsed electromagnetic field therapy (PEMFT) is a reparative technique most commonly used in the field of orthopedics for the treatment of non-union fractures. The aim is to test the effect of the magnetic induction on brute force of treated muscle in oncological patients. Oncology patients were chosen as we assume that the ipmrovement will be more noticable in oncology patients than in a non-oncology, healthy subjects.
- Conditions
- Medical Oncology
- Being tested
- pulsed electromagnetic field therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pulsed electromagnetic field therapyDevice
| Study group | Role | What they receive |
|---|---|---|
| 10 minutes of pulsed electromagnetic field therapy | Other | 10 minutes of pulsed electromagnetic field therapy Receives: Device: pulsed electromagnetic field therapy |
| 20 minutes of pulsed electromagnetic field therapy | Other | 20 minutes of pulsed electromagnetic field therapy Receives: Device: pulsed electromagnetic field therapy |
| 30 minutes of pulsed electromagnetic field therapy | Other | 30 minutes of pulsed electromagnetic field therapy Receives: Device: pulsed electromagnetic field therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Brute force
Measured: 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Dec 2014 (estimated)
- Study startJan 2015
- Primary completionJan 2016 (estimated)
- Study completionMar 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medical OncologyStudies of the same condition, open and under way.
- More trials run by Tel-Aviv Sourasky Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02327806
- Sponsor's protocol ID
- 483-14-TLV
- Status last verified
- Dec 2014
- First submitted
- 24 Dec 2014
- Last updated
- 30 Dec 2014
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Dec 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance
- ClinicalTrials.gov ID
- NCT02327806
- Acronym / sponsor ID
- 483-14-TLV
- Conditions
- Medical Oncology
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Tel-Aviv Sourasky Medical CenterOther government
- Study start
- Jan 2015
- Primary completion
- Jan 2016 (estimated)
- Study completion
- Mar 2016 (estimated)
- First posted
- 30 Dec 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pulsed electromagnetic field therapy (PEMFT) is a reparative technique most commonly used in the field of orthopedics for the treatment of non-union fractures. The aim is to test the effect of the magnetic induction on brute force of treated muscle in oncological patients. Oncology patients were chosen as we assume that the ipmrovement will be more noticable in oncology patients than in a non-oncology, healthy subjects.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| 10 minutes of pulsed electromagnetic field therapy | Other | Device: pulsed electromagnetic field therapy10 minutes of pulsed electromagnetic field therapy |
| 20 minutes of pulsed electromagnetic field therapy | Other | Device: pulsed electromagnetic field therapy20 minutes of pulsed electromagnetic field therapy |
| 30 minutes of pulsed electromagnetic field therapy | Other | Device: pulsed electromagnetic field therapy30 minutes of pulsed electromagnetic field therapy |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patiant from the oncology clinic
Key exclusion criteria (6 listed)
- Known bone disease
- Pregnancy
- Birth defects or acquired uper extremity
- Neurology disease
- Medical history in the forehand
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pulsed electromagnetic field therapy | Device | 10 minutes of pulsed electromagnetic field therapy, 20 minutes of pulsed electromagnetic field therapy, 30 minutes of pulsed electromagnetic field therapy |
Primary outcome
Brute force
Time frame: 2 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Dec 2014.
Related trials for Medical Oncology
RecruitingObservational study
A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Low-volume Metastasis
Active, not recruiting
Ovarian Tissue Cryopreservation in Children
Cancer
Enrolling by invitationObservational study
Liver Transplantation Versus Conventional Medical Therapy for Low-Grade GEP-NET With Liver Metastases
Neuroendocrine Tumors
Active, not recruitingObservational study
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
Neuroendocrine Tumors, NET
Not yet recruitingObservational study
Federated Learning in Renal Tumor Model
Renal Tumors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing pulsed electromagnetic field therapy in people with Medical Oncology, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Dec 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Brute force (time frame: 2 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2014.